Miao Li, Jessica Bi, and Hazem Al-Yacoub Contribute Featured Article to the Newly Released 2025 Blue Book of Pharmaceutical Industry

Blue Book of Pharmaceutical Industry: Annual Report on the Development of China's Pharmaceutical Industry (2025) has been officially released. Compiled by the China Chemical Pharmaceutical Industry Association (CCPIA), this comprehensive annual report serves as a vital resource, systematically capturing the current state and future trends of China's pharmaceutical sector.

The report is structured around six key sections: General Overview, Policies and Regulations, Industry Development, Pharmaceutical Market, Technological Innovation, and Green Pharmaceutical Practices. It provides an in-depth analysis of the 2025 landscape, highlighting critical advancements in industrial operations, technological breakthroughs, business development collaborations, and market structures.

A standout highlight of the book is the featured article titled "Pharmaceutical Market Landscape in the Middle East and Entry Strategies for Chinese Pharmaceutical Enterprises," co-authored by Ms. Miao Li, Ms. Jessica Bi, and Mr. Hazem Al-Yacoub from IPDataLab and Pi Pharma. This pivotal contribution offers invaluable strategic insights into opportunities and challenges for Chinese pharma companies venturing into the Middle East, positioning it as a key section for readers focused on global expansion.